Innovation

Composition and Method for Achieving Immune Suppression (BIDMC 385)

Beth Israel Deaconess Medical Center
posted on 01/14/2012

This patent case claims methods of treatment for cancers, in particular leukemias, based on patient FBW7 mutation status.


Innovation Details
 

File Number: 809 

Other Information:

Investigator(s)
Dr. Terry Strom

Contact
Stanley, Mah C


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Abi Barrow at Beth Israel Deaconess Medical Center for more information.

Request more info via email request more info
People

Case Manager:

Abi Barrow Abi Barrow

Innovations (0)

Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
3428

Beth Israel Deaconess Medical Center


Communities
Profile
Related Tags

Find more innovations

February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...